Altimmune Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
4.32
0.13
(3.103%)
Volume:
3,669,171
52 week range:
3.83 - 23.49
Market Cap:
212.885M
Company Description:
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Its diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).